CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Material agreement
- 8-K/A Event Executive or director change
- 8-K Event Other events
- 8-K Event Executive or director change
- EFFECT Other Notice of Effectiveness
- 424B2 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- 8-K Event Other events
- 4 Open-market buy Director bought 8,600 shares at $2.90 ($24,940)
- 4 Open-market buy President & CEO bought 150,000 shares at $2.76 ($414,000)
- 4 Open-market buy President & CEO bought 73,385 shares at $2.75 ($201,809)
- S-3 Offering Registration Statement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change · Regulation FD disclosure
Page 2 of 62 · 1,225 filings